1. 104 APG101 (SOLUBLE CD95-FC) IMPROVES BFU-E GROWTH IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH COLLAPSED ERYTHROPOIESIS: A PRECLINICAL STUDY. Issue 1 (April 2015) Authors: Raimbault, A.; Bondu, S.; Pierre-Eugene, C.; Deudon, C.; Willems, L.; Frisan, E.; Chapuis, N.; Sapena, R.; Rouquette, A.; Kunz, C.; Fricke, H.; Kosmider, O.; Bardet, V.; Fontenay, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 109 CLINICAL AND MOLECULAR PREDICTORS OF RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN LOWER RISK MDS PATIENTS. (April 2015) Authors: Kosmider, O.; Passet, M.; Santini, V.; Platzbecker, U.; Andrieu, V.; Zini, G.; Beyne-Rauzy, O.; Guerci, A.; Slama, B.; Fenaux, P.; Dreyfus, F.; Fontenay, M.; Park, S. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 148 CLONAL EVOLUTION OF HEMATOPOIETIC STEM CELL UNDER TREATMENT BY LENALIDOMIDE IN NON DEL(5Q) MDS. Issue 1 (April 2015) Authors: Chesnais, V.; Renneville, A.; Toma, A.; Passet, M.; Gauthier, A.; Delaunay, J.; Rose, C.; Stamatoullas, A.; Beyne-Rauzy, O.; Fenaux, P.; Dreyfus, F.; Preudhomme, C.; Fontenay, M.; Kosmider, O. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 159 CSNK1A1 IS NORMALLY EXPRESSED AND UNMUTATED IN MDS PATIENTS WITHOUT DEL(5Q) BEFORE AND UNDER TREATMENT WITH LENALIDOMIDE. Issue 1 (April 2015) Authors: Chesnais, V.; Passet, M.; Bondu, S.; Toma, A.; Fenaux, P.; Dreyfus, F.; Fontenay, M.; Kosmider, O.; GFM, Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. (1st March 2022) Authors: Georgin‐Lavialle, S.; Terrier, B.; Guedon, A.F.; Heiblig, M.; Comont, T.; Lazaro, E.; Lacombe, V.; Terriou, L.; Ardois, S.; Bouaziz, J.‐D.; Mathian, A.; Le Guenno, G.; Aouba, A.; Outh, R.; Meyer, A.; Roux‐Sauvat, M.; Ebbo, M.; Zhao, L.P.; Bigot, A.; Jamilloux, Y. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. (28th November 2021) Authors: Georgin‐Lavialle, S.; Terrier, B.; Guedon, A.F.; Heiblig, M.; Comont, T.; Lazaro, E.; Lacombe, V.; Terriou, L.; Ardois, S.; Bouaziz, J.‐D.; Mathian, A.; Le Guenno, G.; Aouba, A.; Outh, R.; Meyer, A.; Roux‐Sauvat, M.; Ebbo, M.; Zhao, L.P.; Bigot, A.; Jamilloux, Y. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES. (May 2023) Authors: Bernard, E.; Hasserjian, R.; Greenberg, P.; Ossa, J. Arango; Creignou, M.; Nannya, Y.; Tuechler, H.; Medina-Martinez, J.; Levine, M.; Jädersten, M.; Germing, U.; Sanz, G.; Van De Loosdrecht, A.; Kosmider, O.; Follo, M.; Thol, F.; Zamora, L.; Pinheiro, R.; Pellagatti, A.; Elias, H. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?. (May 2023) Authors: Santini, V.; Bejar, R.; Belli, C.; Buckstein, R.; Campelo, M.; Dezern, A.; Fontenay, M.; Griffiths, E.; Grille, S.; Haferlach, T.; Iastrebner, M.; Kosmider, O.; Magalhaes, S.; Mittelman, M.; Platzbecker, U.; Wei, A.; Zeidan, A. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS04-MDS Biology and Pathogenesis/AS04e-Spliceosome machinery: DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION. (May 2023) Authors: Rombaut, D.; Lefevre, C.; Farhat, B.; Bondu, S.; Letessier, A.; Lesieur-Pasquier, A.; Castillo-Guzman, D.; Leduc, M.; Hartono, S.; Chesnais, V.; Mangione, R.; Boussaid, I.; Houy, A.; Bouscary, D.; Willems, L.; Chapuis, N.; Kosmider, O.; Park, S.; Raynaud, S.; Cluzeau, T. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗